GlassScriptPhysician profile
Chad D Hummel
NPI 1770877284
$17,979.14
in general payments reported to CMS, 2019-2025
30 companies · $1,732 in 2025
The $1,732 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,105 · 2020: $648 · 2021: $1,414 · 2022: $1,484 · 2023: $7,263 · 2024: $2,334 · 2025: $1,732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,379 · Consulting Fee: $4,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,378.56 |
| Consulting Fee | $4,950.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $6,052.71 | 2022-2025 | Envista Mx60 Iol, Trulign Iol, Crystalens Accommodating Iol (At-52ao) |
| Glaukos Corporation | $1,756.27 | 2019-2025 | Idose, Istent Infinite Trabecular Micro-Bypass System Model Is3, Idosetr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,596.92 | 2019-2021 | |
| Abbvie INC. | $1,198.13 | 2023-2025 | |
| Alcon Vision LLC | $1,120.64 | 2021-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Lensar, INC. | $1,055.96 | 2019-2024 | Lensar Laser System |
| New World Medical,INC. | $836.85 | 2019-2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Mallinckrodt Hospital Products INC. | $698.51 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $685.46 | 2021-2025 | Tecnis Iol, Amo Phaco Needle, Tecnis Iol |
| Novartis Pharmaceuticals Corporation | $517.97 | 2019-2023 | |
| Sight Sciences, INC. | $470.30 | 2023-2025 | Omni Surgical System, Sion Surgical Instrument |
| Allergan, INC. | $397.07 | 2019-2022 | |
| Carl Zeiss Meditec USA, INC. | $226.88 | 2023-2024 | Visumax, Quatera 700, Atlas 500 |
| Eyevance Pharmaceuticals LLC | $223.16 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $180.42 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $156.80 | 2019-2020 | |
| Ocular Therapeutix, INC. | $135.57 | 2019-2023 | Dextenza |
| Dompe US, INC. | $107.94 | 2022-2025 | Oxervate |
| Rxsight INC | $91.53 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Tarsus Pharmaceuticals, INC. | $75.96 | 2024-2025 | Xdemvy |
| Nova Eye, INC. | $72.03 | 2024 | |
| Sun Pharmaceutical Industries INC. | $54.70 | 2020-2021 | |
| Genentech USA, INC. | $53.64 | 2024-2025 | Vabysmo |
| Oyster Point Pharma, INC. | $50.70 | 2022-2024 | Ryzumvi, Tyrvaya |
| Biotissue Holdings INC. | $42.51 | 2019 | |
| Rayner Intraocular Lenses Limited | $28.81 | 2024 | Rayone Aspheric, Rayone Emv, Omidria |
| Eyepoint US, INC. | $27.00 | 2019-2020 | |
| Horizon Therapeutics Plc | $23.16 | 2022 | |
| Beaver-Visitec International, INC. | $22.19 | 2021 | |
| Shire North American Group INC | $19.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Hummel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.